drugset
drugset / Trial / NCT00984854

Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy Subjects

NCT00984854 ↗

Phase 1 Completed 70 enrolled Renovo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to investigate the safety and toleration of various doses of intradermal Juvidex (mannose-6-phosphate) administered to punch biopsies of normal subjects.

Timeline

Start
2004-01
Primary completion
2004-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Juvidex Unknown 50 unknown Other
Subject Juvidex Unknown 100 unknown Other
Subject Juvidex Unknown 200 unknown Other
Subject Juvidex Unknown 300 unknown Other
Subject Juvidex Unknown 400 unknown Other
Subject Juvidex Unknown 600 unknown Other

Indications

No indication recorded.